BamSEC and AlphaSense Join Forces
Learn More

Tobira Therapeutics, Inc.

Formerly NASDAQ: TBRA
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q/A 64 pages License Agreement
12/34/56
EX-10.1
from 10-Q/A 64 pages License Agreement
12/34/56
EX-10.2
from 10-Q/A 64 pages License Agreement
12/34/56
EX-10.1
from 10-Q/A 64 pages License Agreement
12/34/56
EX-10.2
from 10-Q 64 pages License Agreement
12/34/56
EX-10.1
from 10-Q 64 pages License Agreement
12/34/56
EX-10.20
from 10-Q 2 pages Tobira Therapeutics, Inc. Compensation Program for Non-Employee Directors Effective as of July 2015
12/34/56
EX-10.19
from 10-Q 5 pages Consulting Agreement
12/34/56
EX-10.18
from 10-Q 7 pages Tobira Therapeutics, Inc. Management Cash Incentive Plan
12/34/56
EX-10.17
from 10-Q 5 pages Consulting Agreement
12/34/56
EX-10.16
from 10-Q 12 pages Warrant to Purchase Stock
12/34/56
EX-10.14
from 10-Q 66 pages Office Lease by and Between Dwf III Gateway, LLC, a Delaware Limited Liability Company, as Landlord and Tobira Therapeutics, Inc., a Delaware Corporation, as Tenant for Leased Premises at Suite 300, 701 Gateway Boulevard, South San Francisco, California
12/34/56
EX-10.13
from 10-Q 7 pages November 24, 2011 Eric A. Lefebvre, M.D. Dear Eric: Tobira Therapeutics, Inc. (The “Company”) Is Pleased to Offer You Employment on the Following Terms
12/34/56
EX-10.12
from 10-Q 9 pages Warrant to Purchase Stock
12/34/56
EX-10.11
from 10-Q 8 pages Tobira Therapeutics, Inc. 701 Gateway Blvd, Suite 200 South San Francisco, Ca 94080 February 13, 2014
12/34/56
EX-10.10
from 10-Q 4 pages Tobira Therapeutics, Inc. April 29, 2014
12/34/56
EX-10.9
from 10-Q 4 pages July 23, 2011 Helen Jenkins Dear Helen, Tobira Therapeutics, Inc. (The “Company”) Is Pleased to Offer You Employment on the Following Terms
12/34/56
EX-10.8
from 10-Q 8 pages Tobira Therapeutics, Inc. 701 Gateway Blvd., Suite 200 South San Francisco, Ca, 94080 March 24, 2014
12/34/56
EX-10.7
from 10-Q 8 pages Tobira Therapeutics, Inc . 701 Gateway Blvd, Suite 200 South San Francisco, Ca, 94080 March 17, 2014
12/34/56
EX-10.4
from 10-Q 19 pages Tobira Therapeutics, Inc. 2013 Equity Compensation Plan
12/34/56